916326-80-2 Usage
Uses
Used in Pharmaceutical Research:
Methyl 5-bromo-1-methyl-1H-pyrazolo[3,4-b]pyridine-3-carboxylate is used as a research compound for exploring its potential bioactive properties. Its unique structure makes it a promising candidate for the development of new drugs and therapeutic agents.
Used in Drug Development:
In the field of drug development, Methyl 5-bromo-1-methyl-1H-pyrazolo[3,4-b]pyridine-3-carboxylate is utilized as a starting material or intermediate in the synthesis of novel pharmaceuticals. Its physical and chemical properties allow for further study and optimization in the design of new drugs with improved efficacy and safety profiles.
Used in Medicinal Chemistry:
Methyl 5-bromo-1-methyl-1H-pyrazolo[3,4-b]pyridine-3-carboxylate is employed as a key component in medicinal chemistry, where it can be modified and studied to understand its interactions with biological targets. This knowledge can be applied to the development of more effective and selective drugs for various diseases and conditions.
Used in Drug Design:
In the realm of drug design, Methyl 5-bromo-1-methyl-1H-pyrazolo[3,4-b]pyridine-3-carboxylate serves as a valuable building block for creating new molecular entities. Its unique structural features can be leveraged to design drugs with specific properties, such as improved pharmacokinetics, enhanced potency, or reduced side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 916326-80-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,6,3,2 and 6 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 916326-80:
(8*9)+(7*1)+(6*6)+(5*3)+(4*2)+(3*6)+(2*8)+(1*0)=172
172 % 10 = 2
So 916326-80-2 is a valid CAS Registry Number.
916326-80-2Relevant academic research and scientific papers
Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agents
Lin, Ronghui,Connolly, Peter J.,Lu, Yanhua,Chiu, George,Li, Shengjian,Yu, Yang,Huang, Shenlin,Li, Xun,Emanuel, Stuart L.,Middleton, Steven A.,Gruninger, Robert H.,Adams, Mary,Fuentes-Pesquera, Angel R.,Greenberger, Lee M.
, p. 4297 - 4302 (2008/02/11)
A series of 3,5-disubstituted pyrazolo[3,4-b]pyridine cyclin-dependent kinase (CDK) inhibitors was synthesized. These compounds showed potent and selective CDK inhibitory activities and inhibited in vitro cellular proliferation in cultured human tumor cel
3-BENZOIMIDAZOLYL-PYRAZOLOPYRIDINES USEFUL IN TREATING KINASE DISORDERS
-
Page/Page column 102, (2008/06/13)
The present invention is directed to novel 3-benzoimidazolyl-pyrazolopyridine compounds of formula (I): and pharmaceutically acceptable forms thereof and their synthesis and use as inhibitors of serine-threonine protein kinases and tyrosine protein kinases and interactions thereof.
